{{Drugbox
| verifiedrevid = 447764085
| IUPAC_name = ''N''-ethyl-''N''-methyl-4,4-dithiophen-2-yl-but-3-en-2-amine
| image = Ethylmethylthiambutene structure.svg
| width = 140

<!--Clinical data-->
| tradename =  
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA = Schedule I
| legal_US = Schedule I
| legal_DE = Anlage I
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 441-61-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 46424
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01468
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 42256
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 722BFZ899Q

<!--Chemical data-->
| C=15 | H=19 | N=1 | S=2 
| molecular_weight = 277.45 g/mol
| smiles = CCN(C)C(C)C=C(C1=CC=CS1)C2=CC=CS2
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H19NS2/c1-4-16(3)12(2)11-13(14-7-5-9-17-14)15-8-6-10-18-15/h5-12H,4H2,1-3H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = MORSAEFGQPDBKM-UHFFFAOYSA-N
| melting_point =  
| melting_high =  
}}

'''Ethylmethylthiambutene''' (''N''-ethyl-''N''-methyl-1-methyl-3,3-di-2-thienylallylamine; '''Emethibutin''') is an [[opioid]] [[analgesic]] drug from the [[thiambutene]] family, around 1.3x the potency of [[morphine]].<ref>{{cite journal | last1 = Adamson | first1 = DW | last2 = Green | first2 = AF | title = A new series of analgesics | journal = Nature | volume = 165 | issue = 4186 | pages = 122–122 | year = 1950 | pmid = 15409854 | doi = 10.1038/165122a0 }}</ref><ref>{{cite journal | last1 = Adamson | first1 = DW | last2 = Duffin | first2 = WM | last3 = Green | first3 = AF | title = Dithienylbutylamines as analgesics | journal = Nature | volume = 167 | issue = 4239 | pages = 153–4 | year = 1951 | pmid = 14806409 | doi = 10.1038/167153b0 }}</ref><ref>{{cite journal | last1 = Green | first1 = AF | title = Analgesic and other properties of 3: 3-dithienylalkenylamines | journal = British Journal of Pharmacology and Chemotherapy | volume = 8 | issue = 1 | pages = 2–9 | year = 1953 | pmid = 13066683 | pmc = 1509239 | doi=10.1111/j.1476-5381.1953.tb00739.x}}</ref> It is under international control under Schedule I of the UN Single Convention On Narcotic Drugs 1961, presumably due to high abuse potential.  
It is a Schedule I controlled substance in the United States with a DEA ACSCN of 9623 and zero annual manufacturing quota as of 2013.{{citation needed|date=June 2014}}

==References==
{{Reflist|2}}

{{Analgesics}}
{{Opioidergics}}

[[Category:Synthetic opioids]]
[[Category:Thiophenes]]
[[Category:Amines]]
[[Category:Mu-opioid agonists]]


{{analgesic-stub}}